Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-25 @ 4:31 AM
Ignite Modification Date:
2025-12-26 @ 3:34 AM
NCT ID:
NCT01750918
Population Description:
Since, BRAF V600 mutant patients (MBRAF population) and KRAS wildtype patients progressing after EGFR based therapy (anti-EGFR population) were categorized as biologically distinct populations, doublet combination Trametinib + Panitumumab (T+P) was split into MBRAF and anti-EGFR patients for Baseline Characteristics and efficacy analysis to allow a more meaningful interpretation of study results.
Study:
NCT01750918
Study Brief:
Results Section:
NCT01750918